Virginie Charasson

509 citations
12 papers · 412 indexed · h-index 10
Topics
Cancer therapeutics and mechanisms (6 papers)Pharmacogenetics and Drug Metabolism (3 papers)Epigenetics and DNA Methylation (2 papers)

In The Last Decade

Virginie Charasson

12 papers receiving 401 citations

Peers

Virginie Charasson
Comparison fields: 5 of 73
  • Molecular Biology 183
  • Oncology 129
  • Biomedical Engineering 96
  • Biomaterials 91
  • Materials Chemistry 72
Replace Wenqi Jiang with:
Wenqi Jiang China
Qie Guo China
Pingping Wu China
Dapeng Wei China
James J. Beaudoin United States
Hegen Li China
Huige Peng China
Kuo‐Hsiang Chuang Taiwan
Xiangping Song China
Franciska J. Koopman Netherlands
Virginie Charasson relative to Wenqi Jiang China Wenqi Jiang's profile →
Citations per field
00.5×1.5×
Wenqi Jiang · 1×
Citations per year

Countries citing papers authored by Virginie Charasson

Since Specialization
Citations

This map shows the geographic impact of Virginie Charasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Charasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Charasson more than expected).

Fields of papers citing papers by Virginie Charasson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Charasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Charasson. The network helps show where Virginie Charasson may publish in the future.

Co-authorship network of co-authors of Virginie Charasson

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Charasson. A scholar is included among the top collaborators of Virginie Charasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Charasson. Virginie Charasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 16
2 137
3 16
4 49
5 3
6 19
7 19
8 56
9
Cellular parameters predictive of the clinical response of colorectal cancers to irinotecan. A preliminary study.
14
10 33
11 46
12
In vitro study of the percutaneous absorption of four aromatic amines using hairless rat skin.
4

About Virginie Charasson

Virginie Charasson is a scholar working on Pharmacology, Toxicology and Rheumatology, having authored 12 papers that have together received 412 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Biomaterials (91 citations), Pharmacology (56 citations) and Oncology (129 citations). Virginie Charasson has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Jacques Robert, Sébastien Richeter, Marie‐Christine Haaz, Alain Morère, Marcel Garcia, David Brevet, Philippe Maillard, Ricardo Bellott, Jean‐Olivier Durand and Laurence Raehm. Their work appears in journals such as British Journal of Cancer, International Journal of Pharmaceutics and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026